Inventor · disambiguated record
Theresa Lavallee
Also filed as: LAVALLEE THERESA · LAVALLEE THERESA M · LAVALLEE THERESA MARIE
7 granted patents·14 pending applications·22 citations·filing 2001–2024
80Inventor score
Files withAGOSTON GREGORY E5CELLDEX THERAPEUTICS INC5ENTREMED INC3APEXIGEN AMERICA INC1KOLLTAN PHARMACEUTICALS INC1
Top patents by PatentIndex Score
21 records- 0187US10239943B2Treatment of eosinophil or mast cell related disordersKOLLTAN PHARMACEUTICALS INC·Filed 2015·Granted Mar 26, 2019·6 cites·6 claims
- 0286US10774146B2Treatment of eosinophil or mast cell related disordersCELLDEX THERAPEUTICS INC·Filed 2019·Granted Sep 15, 2020·2 cites·7 claims
- 0384US2024287180A1Treatment of eosinophil or mast cell related disordersCELLDEX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0479US7371741B2Estradiol derivatives and pharmaceutical compositions using sameENTREMED INC·Filed 2004·Granted May 13, 2008·11 cites·9 claims
- 0572US11987626B2Treatment of eosinophil or mast cell related disordersCELLDEX THERAPEUTICS INC·Filed 2020·Granted May 21, 2024·0 cites·7 claims
- 0659US7135581B2Antiangiogenic agentsENTREMED INC·Filed 2001·Granted Nov 14, 2006·3 cites·2 claims
- 0758US2008234243A1Method of treating amyloidosis mediated diseasesLAVALLEE THERESA M·Filed 2008·Application pending·0 cites
- 0854US8158612B2Methods of treating disease states using antiangiogenic agentsAGOSTON GREGORY E·Filed 2008·Granted Apr 17, 2012·0 cites·18 claims
- 0954US2018362443A1Uses of anti-her3 antibodies for treating cancerCELLDEX THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1052US7498322B2Antiangiogenic agentsENTREMED INC·Filed 2005·Granted Mar 3, 2009·0 cites·4 claims
- 1149US2007135400A1Estradiol derivativesAGOSTON GREGORY E·Filed 2007·Application pending·0 cites
- 1248US2007185069A1Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agentsPLUM STACY M·Filed 2006·Application pending·0 cites
- 1348US2007010505A1Methods of treating disease states using antiangiogenic agentsAGOSTON GREGORY E·Filed 2006·Application pending·0 cites
- 1444US2024252633A1Methods of treating cancer with cd-40 agonistsAPEXIGEN AMERICA INC·Filed 2022·Application pending·0 cites
- 1539US2010113404A1Anti-angiogenic activity of 2-methoxyestradiol analogs in combination with anti-cancer agentsLAVALLEE THERESA·Filed 2008·Application pending·0 cites
- 1638US2007004689A1Antiangiogenic agentsAGOSTON GREGORY E·Filed 2006·Application pending·0 cites
- 1738US2005192258A1Antiangiogenic agentsFiled 2005·Application pending·0 cites
- 1834US2006063930A1Compositions and methods comprising proteinase activated receptor antagonistsAGOSTON GREGORY E·Filed 2005·Application pending·0 cites
- 1932US2011256155A1Methods to molecularly characterize circulating tumor cellsMEDIMMUNE LLC·Filed 2011·Application pending·0 cites
- 2030US2018171027A1Biomarkers Related to Treatment of Cancer with HER3 and EGFR InhibitorsCELLDEX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2121US2017190788A1Uses of anti-her3 antibodies for treating cancerLAVALLEE THERESA MARIE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Theresa Lavallee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →